Response files RAMP test in the US and Canada:
This article was originally published in Clinica
Response Biomedical (Vancouver, Canada) has filed applications in both Canada and the US for permission to market its point-of-care RAMP reader and its first RAMP whole blood test. The test is for the heart attack marker, myoglobin. The RAMP system will be able to produce laboratory-comparable results in just 10 minutes, says the company.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.